Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 8/12/11 → 12/31/15 |
Funding
- Pfizer Inc.: $42,690.00
A Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Sfaety of PF-04236921 in subjects with Crohn's Disease Who are Anti-TNF Inadequate Responders
- Flomenhoft, Deborah (PI)
- De Villiers, Willem (Former PI)